Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JOHN W. who wrote (932)	7/11/1997 1:14:00 AM
From: Jim	of 6136

Dont give Dave so much air time. AGPH is volatile and he will have his moments to shine, although brief. The stock is a momentum play at the moment, and also one of the ONLY success stories in biotech in the last year. AGPH has alot going for it....great management, approval, and the potential to do 200-300 million in the first 12 months with Viracept. AGPH has risk of another drug or approach to fighting aids coming along which would make some of the PIs weaker. Nothing at the moment indicates this. The stock will be volatile. Long term in the stock at the moment looks great, which might explain the strength in the stock. Buy the dips.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next